Bionovate Technologies (BIIO) 10-Q 2016 Q1 Quarterly report

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Chris Tong Tang, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	the Annual Report on Form 10-K of MJP International Ltd. for the year ended September 30, 2015 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of MJP International Ltd.

Dated: November 18, 2015

/s/Chris Tong Tang

Chris Tong Tang

President, Chief Executive Officer, and Director

(Principal Executive Officer, Principal Financial Officer

and Principal Accounting Officer)

MJP International Ltd.

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to MJP International Ltd. and will be retained by MJP International Ltd. and furnished to the Securities and Exchange Commission or its staff upon request.